Altered telomeres in tumors with ATRX and DAXX mutations - PubMed (original) (raw)

. 2011 Jul 22;333(6041):425.

doi: 10.1126/science.1207313. Epub 2011 Jun 30.

Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar, G Johan Offerhaus, Roger McLendon, B Ahmed Rasheed, Yiping He, Hai Yan, Darell D Bigner, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Gregory J Riggins, Kenneth W Kinzler, Bert Vogelstein, Ralph H Hruban, Anirban Maitra, Nickolas Papadopoulos, Alan K Meeker

Affiliations

Altered telomeres in tumors with ATRX and DAXX mutations

Christopher M Heaphy et al. Science. 2011.

Abstract

The proteins encoded by ATRX and DAXX participate in chromatin remodeling at telomeres and other genomic sites. Because inactivating mutations of these genes are common in human pancreatic neuroendocrine tumors (PanNETs), we examined the telomere status of these tumors. We found that 61% of PanNETs displayed abnormal telomeres that are characteristic of a telomerase-independent telomere maintenance mechanism termed ALT (alternative lengthening of telomeres). All of the PanNETs exhibiting these abnormal telomeres had ATRX or DAXX mutations or loss of nuclear ATRX or DAXX protein. ATRX mutations also correlate with abnormal telomeres in tumors of the central nervous system. These data suggest that an alternative telomere maintenance function may operate in human tumors with alterations in the ATRX or DAXX genes.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Representative images of ALT-positive tumors with ATRX or DAXX mutations. (A) Example of ALT-positive PanNET. Large, ultrabright telomere FISH signals (red) indicative of ALT are marked (arrows). (B)Immunolabeling of the same PanNET shows loss of nuclear DAXX protein in tumor cells. (C) Example of ALT-positive GBM. Large, ultrabright telomere FISH signals (red) indicative of ALT are marked (arrows). (D) Immunolabeling of the same GBM shows loss of nuclear ATRX protein in tumor cells. In (B) and (D), benign endothelial cells (arrowheads) served as positive immunostaining controls. Scale bars, 30 mm.

Similar articles

Cited by

References

    1. Jiao Y, et al. Science. 2011;331:1199. 10.1126/science.1200609. - PMC - PubMed
    1. Xue Y, et al. Proc. Natl. Acad. Sci. U.S.A. 2003;100:10635. - PubMed
    1. Elsaesser SJ, Allis CD. Cold Spring Harb. Symp. Quant. Biol. 2010;75:27. - PubMed
    1. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD. Proc. Natl. Acad. Sci. U.S.A. 2010;107:14075. - PMC - PubMed
    1. Law MJ, et al. Cell. 2010;143:367. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources